Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 6, 2012

Metabolic syndrome is associated with an increased risk of incident atrial fibrillation and a higher rate of atrial fibrillation recurrence following catheter ablation.

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with metabolic syndrome or its individual components

Design

Review

Authors

PKPrabhat KumarBanaras Hindu UniversityAGAnil K. GehiElectrophysiology

Discussion

Loading...

Member takes

Overview

Supports metabolic syndrome as modifiable AF risk factor; leaves open whether intervention reduces incidence or post-ablation recurrence.

Structured PICO

P
Population
Patients with metabolic syndrome or its individual components (obesity, dyslipidemia, hypertension, insulin resistance)

Metabolic syndrome is a significant risk factor for the development of atrial fibrillation and is associated with poorer outcomes and higher recurrence rates following catheter ablation.

Cite This Study

Kumar et al. (2012) studied this question.

synapsesocial.com/papers/6a968b85ff8a6b2115f6b031https://doi.org/10.4022/jafib.647
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1What Do We Currently Know About Metabolic Syndrome and Atrial Fibrillation?2013 · 36 citations
  2. 2The Role of Different Components of Metabolic Syndrome in the Pathogenesis of Atrial Fibrillation2024 · 2 citations
  3. 3Atrial fibrillation and metabolic syndrome: an updated review of mechanisms, risk factors, and therapeutic strategies2026
  4. 4Cardiometabolic Risk Factors and Atrial Fibrillation2013 · 27 citations
  5. 5Primary prevention of atrial fibrillation in patients with metabolic syndrome: correction of modifiable risk factors2021 · 1 citations